THE EVALUATION OF CMV INFECTION FREQUENCY AND RISK FACTORS IN KIDNEY TRANSLANT RECIPIENTS RECEIVING CMV PROPHYLAXIS

被引：0
|
作者：
Ersoy, Alparslan [1 ]
Gultepe, Ahmet [2 ]
Sayilar, Emel Isiktas [1 ]
Akalin, Halis [3 ]
Coskun, Fatih [2 ]
Torlak, Meltem Oner [3 ]
Ayar, Yavuz [1 ]
机构：
[1] Uludag Univ, Fac Med, Dept Internal Med, Div Nephrol, Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Internal Med, Bursa, Turkey
[3] Uludag Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Bursa, Turkey
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP619
引用
收藏
页码：537 / 537
页数：1
相关论文
共 50 条
  • [1] Impact of extended CMV prophylaxis in adult renal transplant recipients at high risk for CMV infection
    Stuckey, Linda J.
    Park, Jeong M.
    Luan, Fu L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 565 - 565
  • [2] Impact of Extended CMV Prophylaxis on CMV Infection in Lung Transplant Recipients
    Dorey-Steins, Z.
    Varghese, P.
    Patel, M.
    Marron, R.
    Myers, C. N.
    Mills, N.
    Chowdhury, J. M.
    Priest, S.
    Zhao, H.
    Brown, J. C.
    Mulhall, P.
    Galli, J.
    Shenoy, K. V.
    Cordova, F. C.
    Criner, G. J.
    Mamary, A. J.
    Sehgal, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] CMV infection and CMV disease in kidney transplant recipients - our experience
    Chrastina, N.
    Zilinska, Z.
    Breza, J., Jr.
    Breza, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (01): : 42 - 42
  • [4] CMV infection and CMV disease in kidney transplant recipients - our experiences
    Chrastina, M.
    Zilinska, Z.
    Breza, J.
    Breza, J., Jr.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (05): : 246 - 246
  • [5] Is CMV Prophylaxis Necessary in CMV Low-Risk Liver Transplant Recipients?
    Fleming, J. N.
    Bowman, L.
    Truscott, C.
    Pilch, N.
    Taber, D.
    Pote, L.
    Powderly, A.
    Mathur, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 474 - 474
  • [6] EVEROLIMUS REDUCES CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS RECEIVING PREEMPTIVE CMV PROPHYLAXIS
    Spagnoletti, Gionata
    Salerno, Maria Paola
    Apponi, Francesca
    Bianchi, Valentina
    Favi, Evaldo
    Jose, Albero Pedroso
    Romagnoli, Jacopo
    Citterio, Franco
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 98 - 98
  • [7] Preemptive management of CMV is associated with lower rates of leukopenia and similar incidence of CMV infection as compared to routine prophylaxis in kidney transplant recipients receiving Campath induction
    Salvalaggio, P
    Kaufman, D
    Gallon, L
    Scholz, L
    Al-Saden, P
    Stuart, F
    Abecassis, M
    Chon, WJ
    Koffron, A
    Fryer, J
    Baker, T
    Leventhal, J
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 494 - 494
  • [8] Rates of CMV Infection in Kidney Transplant Recipients Who Received Subtherapeutic Valganciclovir Prophylaxis
    Belfield, K.
    Cohen, E.
    Malinis, M.
    Baghban, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 514 - 514
  • [9] Quantiferon-CMV Test, CMV-Specific ELISPOT and CMV-Dextramer Assays in Assessing the Risk of CMV Infection in Seropositive Kidney Transplant Recipients
    Lee, H.
    Park, K.
    Ryu, J.
    Yu, J.
    Chung, B.
    Yang, C.
    Oh, E. -J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 691 - 691
  • [10] Risk Factors for Leukopenia with Valganciclovir Prophylaxis in CMV High Risk Cardiothoracic Transplant Recipients
    Brueckner, A. J.
    Doligalski, C. T.
    Logan, A. T.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S365 - S366
12345